Farallon buys shares of Pharmion

By Lisa Kerner

Charlotte, N.C., Feb. 15 - Pharmion Corp. shareholders led by Farallon Capital Partners, LP bought 482,300 shares of the company's stock, it was reported in a schedule 13D filing with the Securities and Exchange Commission.

The shares were acquired between Feb. 4 and Feb. 14, priced from $69.24 to $70.30 per share.

The investors beneficially own 2,800,855 shares, or 7.5%, of the Boulder, Colo., oncology company's common stock.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.